back to cluster viewer
cluster path 10101011010100
63 words, 10,921 tokens
freq alpha suffix
Words in frequency order
1 | short-term | 9,918
|
2 | subchronic | 132
|
3 | short-duration | 131
|
4 | steroid-free | 93
|
5 | long-duration | 75
|
6 | short-time | 75
|
7 | sub-chronic | 62
|
8 | hurricane | 38
|
9 | training-related | 35
|
10 | longer-duration | 29
|
11 | between-session | 28
|
12 | day-by-day | 27
|
13 | shorter-term | 26
|
14 | perpetual | 15
|
15 | shortterm | 15
|
16 | magnetoencephalographic | 14
|
17 | pcr-adjusted | 14
|
18 | within-groups | 14
|
19 | midazolam-induced | 13
|
20 | continuation-phase | 11
|
21 | mode-specific | 11
|
22 | sstgd | 11
|
23 | multiday | 10
|
24 | year-2 | 8
|
25 | 7-wk | 7
|
26 | t0-t1 | 7
|
27 | anti-dandruff | 5
|
28 | nonadjusted | 5
|
29 | pain-reduction | 5
|
30 | precall | 5
|
31 | resveratrol-mediated | 5
|
32 | within-center | 5
|
33 | cbsm-related | 4
|
34 | clinically-meaningful | 4
|
35 | non-mortality | 4
|
36 | nurse-implemented | 4
|
37 | plan-do-study-act | 4
|
38 | pre-/posttreatment | 4
|
39 | 120-s | 3
|
40 | cep/cec | 3
|
41 | expectancy-induced | 3
|
42 | less-frequency | 3
|
43 | participants’ | 3
|
44 | 13,946 | 2
|
45 | 5,469 | 2
|
46 | app-induced | 2
|
47 | cancer-inhibiting | 2
|
48 | current- | 2
|
49 | franz-keldysh | 2
|
50 | icm-associated | 2
|
51 | muda | 2
|
52 | one-appointment | 2
|
53 | operation-specific | 2
|
54 | propranolol-only | 2
|
55 | thiazide-related | 2
|
56 | yoptimal | 2
|
57 | aproportionate | 1
|
58 | derrubon | 1
|
59 | effects.no | 1
|
60 | high-versus | 1
|
61 | non-responders.. | 1
|
62 | product∗ | 1
|
63 | quasiequilibrium | 1
|
Words in alphabetical order
1 | 120-s | 3
|
2 | 13,946 | 2
|
3 | 5,469 | 2
|
4 | 7-wk | 7
|
5 | anti-dandruff | 5
|
6 | app-induced | 2
|
7 | aproportionate | 1
|
8 | between-session | 28
|
9 | cancer-inhibiting | 2
|
10 | cbsm-related | 4
|
11 | cep/cec | 3
|
12 | clinically-meaningful | 4
|
13 | continuation-phase | 11
|
14 | current- | 2
|
15 | day-by-day | 27
|
16 | derrubon | 1
|
17 | effects.no | 1
|
18 | expectancy-induced | 3
|
19 | franz-keldysh | 2
|
20 | high-versus | 1
|
21 | hurricane | 38
|
22 | icm-associated | 2
|
23 | less-frequency | 3
|
24 | long-duration | 75
|
25 | longer-duration | 29
|
26 | magnetoencephalographic | 14
|
27 | midazolam-induced | 13
|
28 | mode-specific | 11
|
29 | muda | 2
|
30 | multiday | 10
|
31 | non-mortality | 4
|
32 | non-responders.. | 1
|
33 | nonadjusted | 5
|
34 | nurse-implemented | 4
|
35 | one-appointment | 2
|
36 | operation-specific | 2
|
37 | pain-reduction | 5
|
38 | participants’ | 3
|
39 | pcr-adjusted | 14
|
40 | perpetual | 15
|
41 | plan-do-study-act | 4
|
42 | pre-/posttreatment | 4
|
43 | precall | 5
|
44 | product∗ | 1
|
45 | propranolol-only | 2
|
46 | quasiequilibrium | 1
|
47 | resveratrol-mediated | 5
|
48 | short-duration | 131
|
49 | short-term | 9,918
|
50 | short-time | 75
|
51 | shorter-term | 26
|
52 | shortterm | 15
|
53 | sstgd | 11
|
54 | steroid-free | 93
|
55 | sub-chronic | 62
|
56 | subchronic | 132
|
57 | t0-t1 | 7
|
58 | thiazide-related | 2
|
59 | training-related | 35
|
60 | within-center | 5
|
61 | within-groups | 14
|
62 | year-2 | 8
|
63 | yoptimal | 2
|
Words in suffix order
1 | current- | 2
|
2 | non-responders.. | 1
|
3 | t0-t1 | 7
|
4 | year-2 | 8
|
5 | 13,946 | 2
|
6 | 5,469 | 2
|
7 | muda | 2
|
8 | cep/cec | 3
|
9 | mode-specific | 11
|
10 | operation-specific | 2
|
11 | magnetoencephalographic | 14
|
12 | sub-chronic | 62
|
13 | subchronic | 132
|
14 | midazolam-induced | 13
|
15 | app-induced | 2
|
16 | expectancy-induced | 3
|
17 | icm-associated | 2
|
18 | resveratrol-mediated | 5
|
19 | thiazide-related | 2
|
20 | training-related | 35
|
21 | cbsm-related | 4
|
22 | nurse-implemented | 4
|
23 | pcr-adjusted | 14
|
24 | nonadjusted | 5
|
25 | sstgd | 11
|
26 | steroid-free | 93
|
27 | short-time | 75
|
28 | hurricane | 38
|
29 | continuation-phase | 11
|
30 | aproportionate | 1
|
31 | anti-dandruff | 5
|
32 | cancer-inhibiting | 2
|
33 | franz-keldysh | 2
|
34 | 7-wk | 7
|
35 | yoptimal | 2
|
36 | perpetual | 15
|
37 | precall | 5
|
38 | clinically-meaningful | 4
|
39 | shorter-term | 26
|
40 | short-term | 9,918
|
41 | shortterm | 15
|
42 | quasiequilibrium | 1
|
43 | derrubon | 1
|
44 | between-session | 28
|
45 | long-duration | 75
|
46 | longer-duration | 29
|
47 | short-duration | 131
|
48 | pain-reduction | 5
|
49 | effects.no | 1
|
50 | within-center | 5
|
51 | 120-s | 3
|
52 | within-groups | 14
|
53 | high-versus | 1
|
54 | plan-do-study-act | 4
|
55 | pre-/posttreatment | 4
|
56 | one-appointment | 2
|
57 | day-by-day | 27
|
58 | multiday | 10
|
59 | less-frequency | 3
|
60 | propranolol-only | 2
|
61 | non-mortality | 4
|
62 | product∗ | 1
|
63 | participants’ | 3
|